Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Tianeptine in the Treatment of Covid Fog Symptoms in Patients After COVID-19.

NCT06012552 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Nervous System Diseases

Interventions

DRUG: Tianeptine
DRUG: Placebo

Sponsor

Military Institute od Medicine National Research Institute

Collaborators

[object Object]